# Wockhardt

> Mediated Wiki article. Canonical URL: https://mediated.wiki/source/Wockhardt
> Markdown URL: https://mediated.wiki/source/Wockhardt.md
> Source: https://en.wikipedia.org/wiki/Wockhardt
> Source revision: 1349865862
> License: Creative Commons Attribution-ShareAlike 4.0 International (https://creativecommons.org/licenses/by-sa/4.0/)

{{Short description|Pharmaceutical and biotechnology company headquartered in Mumbai, India}}
{{COI|date=June 2021}}
{{Use British English|date=January 2014}}
{{Use dmy dates|date=April 2026}}
{{Infobox company
|name               = Wockhardt Ltd.
|logo               = Wockhardt Logo.png
|image              = Wockhardt Hospital Mumbai.jpg
|image_caption      = Wockhardt global headquarters in [Mumbai](/source/Mumbai)
|type               = [Public](/source/Public_company)
|traded_as          = {{National Stock Exchange of India|WOCKPHARMA}}<br />{{Bombay Stock Exchange|532300}}
|foundation         = 1960s
|founder            = [Habil Khorakiwala](/source/Habil_Khorakiwala)
|location           = Wockhardt Towers, [Bandra Kurla Complex](/source/Bandra_Kurla_Complex), [Mumbai](/source/Mumbai), [Maharashtra](/source/Maharashtra), India
|area_served        = Worldwide
|key_people         = Habil Khorakiwala <small>(Chairman)</small><br />Murtaza Khorakiwala <small>(Managing director)</small><br />Huzaifa Khorakiwala <small>(Executive Director)</small>
|industry           = [Pharmaceutical](/source/Pharmaceutical)s<br />Health care
|products           = [Formulation](/source/Formulation)s<br />[Biopharmaceutical](/source/Biopharmaceutical)s<br />[Vaccine](/source/Vaccine)s
|revenue            = {{decrease}} {{INRConvert|2693|c}} (FY23)<ref name="Revenue"/>
|operating_income   = 
|net_income         = {{negative increase}} {{INRConvert|-621|c}} (FY23)<ref name="Revenue">{{cite news |title=Wockhardt posts net loss of Rs 237 crore in Q4 FY 23 |url=https://www.thehindubusinessline.com/companies/wockhardt-posts-net-loss-of-rs-237-crore-in-q4-fy-23/article66901421.ece |access-date=2 March 2024 |work=The Economic Times |date=27 May 2023}}</ref>
|assets             = 
|equity             = 
|subsid             = Morton Grove Pharma<ref>{{cite news |title=Wockhardt acquires US-based Morton Grove |url=https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/wockhardt-acquires-us-based-morton-grove/articleshow/2485532.cms |access-date=16 February 2023 |work=The Economic Times |date=24 October 2007}}</ref>
|num_employees      = 3,000
|num_employees_year = 2023
|homepage           = {{URL|www.wockhardt.com}}
|footnotes          = <ref name="FY21">{{cite news |title=Audited Financial Results For The Quarter And Year Ended 31.03.2021 |url=https://www.bseindia.com/xml-data/corpfiling/AttachLive/d047be4a-2ebc-4f64-94c1-a8f67a730091.pdf |access-date=27 May 2021 |work=BSE}}</ref>
}}

'''Wockhardt''' is an Indian [pharmaceutical](/source/pharmaceutical) and [biotechnology](/source/biotechnology) company headquartered in [Mumbai](/source/Mumbai), India. It produces [formulation](/source/formulation)s, [biopharmaceutical](/source/biopharmaceutical)s, nutrition products, [vaccine](/source/vaccine)s and [active pharmaceutical ingredient](/source/active_pharmaceutical_ingredient)s (APIs).<ref>{{cite web |url=http://www.wockhardt.com/who-we-are/overview.aspx |title=Wockhardt – Who we are}}</ref> The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France.<ref name="birlaa"/><ref name="bs">{{cite news |date=20 March 2013 |title=Wockhardt set to join billion-dollar club |newspaper=Business Standard India |url=http://www.business-standard.com/article/companies/wockhardt-set-to-join-billion-dollar-club-113031900413_1.html |access-date=20 March 2013 |publisher=Business Standard}}</ref>

==History==
Wockhardt was founded by Dr. [Habil Khorakiwala](/source/Habil_Khorakiwala) in the 1960s.<ref>{{cite web |title=Wockhardt Chairman's Profile |url=http://www.wockhardt.com/who-we-are/chairmans-profile.aspx |website=wockhardt.com |access-date=13 February 2017}}</ref> His father [Fakhruddin T. Khorakiwala](/source/Fakhruddin_T._Khorakiwala) had acquired Worli Chemical Works<ref>{{cite news |url=https://economictimes.indiatimes.com/corporate-dossier/marginal-business-logic/articleshow/2905713.cms |title=Marginal business logic |author=Priyanka Sangani |work=The Economic Times |date=28 March 2008}}</ref> in 1959. This was incorporated as Wockhardt Pvt. Ltd., in 1973.<ref name="birlaa">{{cite journal |author=Sanju Verma, Amit Shah |year=2007 |title=Wockhardt: "Wock"ing the talk... |url=http://birlaa.com/wp-filez/Wockhardt%20Company%20Report.pdf |archive-url=https://web.archive.org/web/20111003184636/http://birlaa.com/wp-filez/Wockhardt%20Company%20Report.pdf |url-status=usurped |archive-date=3 October 2011 |series=India Research |periodical=HDFC Securities}}</ref> Wockhardt Ltd. was incorporated on 8 July 1999.<ref>{{cite web |title=Wockhardt Limited |url=http://www.pharmabiz.com/redfr.asp?fn=/comprof/wockhardt.asp |access-date=9 May 2009 |url-status=dead |archive-url=https://archive.today/20071020220413/http://www.pharmabiz.com/redfr.asp?fn=/comprof/wockhardt.asp |archive-date=20 October 2007}}</ref> In the 1990s, Wockhardt gained market share with its painkiller Proxyvon (opioid [tramadol](/source/tramadol) + [paracetamol](/source/paracetamol)) and blood pressure drugs ([lisinopril](/source/lisinopril), etc.<!-- "aceton" = NO MENTION FOUND -->). In 1995, it expanded into [biotechnology](/source/biotechnology), and subsequently started producing [intravenous fluid](/source/intravenous_fluid)s.<ref>{{cite web |url=https://timesofindia.indiatimes.com/business/india-business/we-need-a-nano-for-medicines-too/articleshow/2712332.cms |author=T. Surendar, Charles Assisi |date=18 January 2008 |title=We need a Nano for medicines too |work=The Times of India}}</ref> In 1999, Wockhardt joined the [Indian Pharmaceutical Alliance](/source/Indian_Pharmaceutical_Alliance) as a founding member in an effort to promote the development of generic drugs in India.<ref>{{Cite news |last=Dec 22 |first=PTILast Updated |date=2022-12-22 |title=Indian pharma sector set for 'volume to value leadership' journey in 2023 |work=The Economic Times |url=https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-pharma-sector-set-for-volume-to-value-leadership-journey-in-2023/articleshow/96407749.cms |access-date=2023-08-06 |issn=0013-0389}}</ref><ref>{{Cite web |title=Introducing IPA- Indian Pharmaceutical Alliance |url=https://www.ipa-india.org/about-ipa/introduction/ |access-date=2023-08-06 |website=IPA, Indian Pharmaceutical Alliance}}</ref>

Wockhardt is the first company outside the US and Europe to manufacture [recombinant human insulin](/source/recombinant_DNA).<ref>{{cite web |url=http://www.wockhardt.co.uk/aboutus/wockhardtinternational.asp |title=Introducing Wockhardt |access-date=9 May 2009}}</ref>

In 2011, Wockhardt sold its nutrition business to [Danone](/source/Danone) for $356 million.<ref>{{cite news |title=Wockhardt sells nutrition biz to Danone for Rs 1,576 cr |url=https://www.business-standard.com/article/companies/wockhardt-sells-nutrition-biz-to-danone-for-rs-1-576-cr-111080300045_1.html |access-date=25 January 2023 |work=Business Standard India |date=3 August 2011}}</ref>

During the [COVID-19 pandemic](/source/COVID-19_pandemic), Wockhardt signed a contract with the [Government of the United Kingdom](/source/Government_of_the_United_Kingdom) to [fill-finish](/source/fill_and_finish) the [Oxford–AstraZeneca COVID-19 vaccine](/source/Oxford%E2%80%93AstraZeneca_COVID-19_vaccine) at the company's facility in [Wrexham](/source/Wrexham), [Wales](/source/Wales). The contract was extended until August 2022.<ref>{{cite news |title=UK extends COVID-19 vaccine supply deal with India's Wockhardt by 6 months |url=https://www.livemint.com/news/world/uk-extends-covid-19-vaccine-supply-deal-with-india-s-wockhardt-by-6-months-11612953273999.html |work=Mint |date=2021-02-10 |language=en}}</ref><ref>{{cite news |title=Wockhardt: the company helping to vaccinate Britain |url=https://www.ft.com/content/9e914600-44ad-4901-8ef5-e7a5d2b0b744 |access-date=28 June 2021 |work=Financial Times}}</ref>

In August 2021, Wockhardt announced that it signed an agreement with Dubai-based Enso Healthcare and Russian firm [Human Vaccine LLC](/source/Russian_Direct_Investment_Fund) to [contract manufacture](/source/contract_manufacturing_organization) the [Sputnik V](/source/Sputnik_V_COVID-19_vaccine) and [Sputnik Light](/source/Sputnik_Light) vaccines in India.<ref>{{cite news |title=Wockhardt to produce, supply Sputnik V, Sputnik Light Covid vaccine |url=https://www.livemint.com/companies/news/wockhardt-to-manufacture-sputnik-v-sputnik-light-covid-vaccine-11628828717909.html |access-date=21 September 2021 |work=mint |date=13 August 2021 |language=en}}</ref>

==Mergers and acquisitions==
Wockhardt's acquisitions include Wallis Laboratory, UK (1998); Merind, India (1998); CP Pharmaceuticals, UK (2003); Espharma GmbH, Germany (2004); [Dumex](/source/Dumex), India (2006); Pinewood Laboratory Ireland (2006); Morton Grove Pharmaceuticals, US (2007);<ref>{{cite news |url=https://www.reuters.com/article/idUSBOM9529820071024 |title=UPDATE 1-Wockhardt buys US Morton Grove for $38 mln |newspaper=Reuters |date=24 October 2007 |via=www.reuters.com}}</ref> and Negma, France (2007).<ref name="birlaa"/> Wockhardt's debt following the acquisitions was close to Rs 38&nbsp;billion, and [Habil Khorakiwala](/source/Habil_Khorakiwala) quit as managing director.<ref>{{cite news |url=http://www.business-standard.com/india/news/newsmaker-habil-f-khorakiwala/353842/ |title=Newsmaker: Habil F Khorakiwala, Scientist in a hurry |author=Shobhana Subramanian |newspaper=Business Standard India |date=3 April 2009 |publisher=Business Standard}}</ref>

On 31 March 2009, the board of directors approved the appointments of Habil Khorakiwala's sons Murtaza Khorakiwala and Huzaifa Khorakiwala as managing director and executive director respectively.<ref>{{Cite web |title=Wockhardt {{!}} Who we are {{!}} Board of Directors |url=http://www.wockhardt.com/who-we-are/directors.aspx |access-date=2022-11-05 |website=www.wockhardt.com}}</ref>

==Philanthropy and education==
[[File:WOCKHARDT 5.jpg|thumb|Wockhardt Global School in [Aurangabad](/source/Aurangabad)]]
* Wockhardt Foundation
* Wockhardt Global Schools

==In popular culture==
{{See also|Lean (drug)}}
Wockhardt is known for producing cough syrup with the [sedative](/source/sedative) [promethazine](/source/promethazine) and the opiate [codeine](/source/codeine), used in the recreational street drug [lean](/source/lean_(drug)), which is sometimes referred to as "Wock", short for Wockhardt.<ref>{{cite news |last1=Bella |first1=Timothy |title=Hip-Hop's Unlikeliest Icons: Promethazine Codeine Syrup Manufacturers |url=https://www.bloomberg.com/news/features/2017-03-09/hip-hop-s-unlikeliest-icons-promethazine-codeine-syrup-manufacturers |access-date=17 May 2022 |work=Bloomberg |date=9 March 2017 |language=en}}</ref>

==Good Manufacturing Practice violations==

In 2013, the United States [Food and Drug Administration](/source/Food_and_Drug_Administration) uncovered widespread fraud in Wockhardt's production of generic medications, such as contamination of injectable drugs in violation of [good manufacturing practice](/source/good_manufacturing_practice). The agency responded by restricting the company's ability to export drugs from its manufacturing plant in [Aurangabad](/source/Aurangabad), India. Wockhardt officials responded by repeatedly threatening the involved FDA inspectors.<ref>{{Cite book |last=Eban |first=Katherine |title=Bottle of Lies |date=2019 |publisher=[HarperCollins](/source/HarperCollins) |isbn=9780062338785 |pages=1–6, 304–307}}</ref>

==See also==
* [Wockhardt Hospitals](/source/Wockhardt_Hospitals)
* [Monginis](/source/Monginis)

==References==
{{Reflist}}

==External links==
* [http://www.wockhardt.com/ Official website]
* [https://wockhardtglobalschool.com Wockhardt Global School]

{{Authority control}}

Category:Pharmaceutical companies of India
Category:Manufacturing companies based in Mumbai
Category:Companies listed on the Bombay Stock Exchange
Category:Companies listed on the National Stock Exchange of India
Category:1960 establishments in Maharashtra
Category:Indian companies established in 1960
Category:Pharmaceutical companies established in 1960

---
Adapted from the Wikipedia article [Wockhardt](https://en.wikipedia.org/wiki/Wockhardt) by Wikipedia contributors ([contributor history](https://en.wikipedia.org/wiki/Wockhardt?action=history)). Available under [Creative Commons Attribution-ShareAlike 4.0 International](https://creativecommons.org/licenses/by-sa/4.0/). Changes may have been made.